Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib and Bone Metabolism in Relapsed/Refractory Multiple Myeloma
NCT02020941Phase 2Terminated
- Start
- Sep 2013
- Primary completion
- Jan 2016
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Sep 2013; status: terminated.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02020941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020941.